CHAD MILLIKAN: Open Payments
NPI 1407375736 · DAKOTA DUNES, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 29 payments from 22 companies in 2025. Trend: 2023 $474 · 2024 $559 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 4 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| ABBVIE INC. | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $28 |
| Procept Biorobotics Corporation | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| 180 Medical, Inc. | 1 | $21 |
| Boston Scientific Corporation | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: Nubeqa, JELMYTO, ZUSDURI, LYNPARZA, BOTOX, ERLEADA, AQUABEAM ROBOTIC SYSTEM, ORGOVYX.
Industry payments across SD — which companies pay providers there.
